Catalent (CTLT) Stock Highlights

60.28 | -0.07%

2024-09-19 16:11:07

Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

Statistics

Range Today

60.21 60.32

Volume Today 698.04K

Range 1 Year

31.8 61.2

Volume 1 Year 540.85M

Range 3 Year

31.45 142.09

Volume 3 Year 1.64B

Range 10 Year

18.92 142.64

Volume 10 Year 3.3B

Highlights

Market Capitalization 10.82B (large)

Floating Shares 180.34M

Current Price 60.28

Price To Earnings -10.33

Price To Revenue 3.54

Price To Book 2.99

Earnings Per Share -5.76

Payout Ratio 0%

Performance

Latest -0.07%

1 Month +1.48%

3 Months +9.66%

6 Months +7.82%

1 Year +27.98%

3 Years -55.06%

5 Years +19.18%

10 Years +149.92%

Benchmarks

Market Capitalization

4 / 54

Gross Profits

7 / 39

Total Revenue

7 / 50

Total Rank

8 / 54

Free Cashflow

50 / 54

Performance 5 years

13 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.